STAT+: Pharmalittle: We’re reading about FDA warnings on CAR-T drugs, a Sanofi deal, and more
The FDA is requiring manufacturers of CAR-T cancer therapies to add a serious warning on the prescribing information about the risk of T-cell malignancies.
Good morning, everyone, and how are you today? We are doing just fine, thank you, despite some cloudy skies hovering overhead. Given that a much-welcomed thaw, of sorts, is under way, there is no
